Uptake of prophylactic surgery to reduce tubo-ovarian cancer risk by women with BRCA mutations is variable.  Australian publications have suggested uptake by 38-56% of mutation carriers.

We explored the uptake of risk reducing surgery amongst 231 women with known BRCA mutations who were under the care of the Tasmanian Clinical genetics service using a postal questionnaire and chart review where possible.

Uptake of prophylactic BSO was 71.9% in this population.  This is higher than reported in other Australian populations and we have tried to explore what factors are influencing women’s choices in this regard.